The risk of developing peripheral neuropathy induced by nucleoside reverse transcriptase inhibitors decreases over time: evidence from the Delta trial. (2008)

First Author: Arenas-Pinto A
Attributed to:  Adult HIV Clinical Trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

PubMed Identifier: 18505180

Publication URI: http://europepmc.org/abstract/MED/18505180

Type: Journal Article/Review

Volume: 13

Parent Publication: Antiviral therapy

Issue: 2

ISSN: 1359-6535